5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer
    Journal Article

    Fury, M. G.; Sherman, E.; Ho, A. L.; Xiao, H.; Tsai, F.; Nwankwo, O.; Sima, C.; Heguy, A.; Katabi, N.; Haque, S.; more...
    Cancer (2013)

    Fulltext@MSK | Save
  • Patient-reported outcomes for axitinib vs sorafenib in metastatic renal cell carcinoma: Phase III (AXIS) trial
    Journal Article

    Cella, D.; Escudier, B.; Rini, B.; Chen, C.; Bhattacharyya, H.; Tarazi, J.; Rosbrook, B.; Kim, S.; Motzer, R.
    British Journal of Cancer (2013)

    Fulltext@MSK | Save
  • Phase II trial of MEK inhibitor selumetinib (AZD6244, ARRY-142886) in patients with BRAFV600E/K-mutated melanoma
    Journal Article

    Catalanotti, F.; Solit, D. B.; Pulitzer, M. P.; Berger, M. F.; Scott, S. N.; Iyriboz, T.; Lacouture, M. E.; Panageas, K. S.; Wolchok, J. D.; Carvajal, R. D.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • Mutant N-RAS protects colorectal cancer cells from stress-induced apoptosis and contributes to cancer development and progression
    Journal Article

    Wang, Y.; Velho, S.; Vakiani, E.; Peng, S.; Bass, A. J.; Chu, G. C.; Gierut, J.; Bugni, J. M.; Der, C. J.; Philips, M.; more...
    Cancer Discovery (2013)

    Fulltext@MSK | Save
  • Effect of abiraterone acetate on fatigue in patients with metastatic castration-resistant prostate cancer after docetaxel chemotherapy
    Journal Article

    Sternberg, C. N.; Molina, A.; North, S.; Mainwaring, P.; Fizazi, K.; Hao, Y.; Rothman, M.; Gagnon, D. D.; Kheoh, T.; Haqq, C. M.; more...
    Annals of Oncology (2013)

    Fulltext@MSK | Save
  • Validation and clinical utility of prostate cancer biomarkers
    Journal Article

    Scher, H. I.; Morris, M. J.; Larson, S.; Heller, G.
    Nature Reviews Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression
    Journal Article

    LoĢpez-Lago, M. A.; Posner, S.; Thodima, V. J.; Molina, A. M.; Motzer, R. J.; Chaganti, R. S. K.
    Oncogene (2013)

    Fulltext@MSK | Save
  • Fibroblast growth factor receptor-3 in urothelial tumorigenesis
    Journal Article

    Iyer, G.; Milowsky, M. I.
    Urologic Oncology: Seminars and Original Investigations (2013)

    Fulltext@MSK | Save
  • Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma
    Journal Article

    Hakimi, A. A.; Chen, Y. B.; Wren, J.; Gonen, M.; Abdel-Wahab, O.; Heguy, A.; Liu, H.; Takeda, S.; Tickoo, S. K.; Reuter, V. E.; more...
    European Urology (2013)

    Fulltext@MSK | Save
  • Identification of Nine Genomic Regions of Amplification in Urothelial Carcinoma, Correlation with Stage, and Potential Prognostic and Therapeutic Value
    Journal Article

    Chekaluk, Y.; Wu, C. L.; Rosenberg, J.; Riester, M.; Dai, Q.; Lin, S.; Guo, Y.; McDougal, W. S.; Kwiatkowski, D. J.
    PLoS ONE (2013)

    Fulltext@MSK | Save